European Union
International Standa...
NGOs
United Nations
Afghanistan
Aland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua & Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia & Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean...
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burma (Myanmar)
Burundi
Cambodia
Cameroon
Canada
Cape Verde Islands
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo (Brazzaville)
Congo, Democratic Re...
Cook Islands
Costa Rica
Cote d'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Terr...
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Hawai
Heard and McDonald I...
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North Korea
Northern Marianas Islands
Norway
Oman
Pakistan
Palau
Palestinian Authority
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia
South Korea
Spain
Sri Lanka
St-Barthelemy
St-Martin
St. Helena
St. Kitts & Nevis
St. Lucia
St. Pierre et Miquelon
St. Vincent & the Gr...
Sudan
Suriname
Svalbard & Jan Mayen...
Swaziland
Sweden
Switzerland
Syria
Taiwan (Republic of ...
Tajikistan
Tanzania
Thailand
Togo
Tokelau
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Turks & Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States (Minor...
United States of America
Uruguay
US Virgin Islands
Uzbekistan
Vanuatu
Vatican City State (...
Venezuela
Vietnam
Wallis & Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe
|
Department of Health and Ageing, Therapeutic Goods Administration (Australian government)
| Report Title: |
Attachment 7: Proposed Model for a Mandatory Notification and Assessment |
| Report ID: |
424 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Assessment and Notification Scheme |
| Report Type: |
Background Document |
| URL: |
[Attachment_7_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
The following attachment contains a proposed model for the mandatory notification and assessment program as described in NICNAS’s Proposal for Regulatory Reform of Industrial Nanomaterials Public Discussion Paper. |
| Archived Copy: |
Attachment_7_PDF_424_2615.pdf |
 |
|
| Report Title: |
Attachment 6: Proposed Strategy for Nano-forms of New-chemicals |
| Report ID: |
423 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment Scheme |
| Report Type: |
Background Document |
| URL: |
[Attachment_6_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
The following attachment contains tables and drawings that illustrate the current regulatory framework for industrial nanomaterials in Australia. Elaborated, this consists of the provisions for new chemicals used in research and development under The Industrial Chemicals Notification and Assessment Act 1989, a summary of the permit categories for regulation of industrial nanomaterials under NICNAS, the proposal for regulation of industrial nanomaterials under NICNAS certificate categories, and a proposed strategy for requesting particle size distribution information for permit and certificate categories. |
| Archived Copy: |
Attachment_6_PDF_423_6363.pdf |
|
|
| Report Title: |
Attachment 5: Overview of NICNAS New Chemical Notification Categories |
| Report ID: |
422 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment |
| Report Type: |
Background Document |
| URL: |
[Attachment_5_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
This attachment contains an overview of NICNAS two new chemical notification categories. The first, permit notification, is suitable for chemicals which meet certain criteria and result in the issue of a permit allowing the introduction of fixed quantities of the chemical for the duration of the permit. The certificate notification, which is the second, is intended for chemicals which do not meet the permit criteria or where the introducer prefers a certificate notification to a permit notification. Certificate categories result in an assessment report, the issue of an assessment certificate, and public publication of the assessed chemical. Additionally, a chemical that has been formally assessed by NICNAS, either as a new or existing chemical, may necessitate a secondary notification assessment due to changed circumstances. The procedure for such reassessment is set in place by Section 64 of the Industrial Chemicals (Notification and Assessment) Act (1989). |
| Archived Copy: |
Attachment_5_PDF_422_5015.pdf |
|
|
| Report Title: |
Attachment 4: Overview of International Activities Addressing Regulation of Industrial Nanomaterials |
| Report ID: |
421 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment |
| Report Type: |
Background Document |
| URL: |
[Attachment_4_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
The following attachment contains overviews of the regulation of industrial nanomaterials from the United States, Canada, the United Kingdom, and the European Union’s REACH regulatory schema. |
| Archived Copy: |
Attachment_4_PDF_421_7062.pdf |
|
|
| Report Title: |
Attachment 3: Summary of Findings from Review of the Possible Impacts of Nanotechnology on Australia’s Regulatory Framework |
| Report ID: |
420 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment Scheme |
| Report Type: |
Background Document |
| URL: |
[Attachment_3_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
Australia’s federal regulatory frameworks are generally well suited to allowing adequate management and control of risks posed by engineered nanomaterials (NM) and products incorporating NM, and their manufacture, use and handling. This review found that there was no case where a particular regulatory framework generally did not apply to a nanofamily as a result of the presence of NMs. Further, the application generally of the federal regulatory frameworks to NMs and products in the nanofamilies meant that regulation throughout the whole of the lifecycle of these materials is largely the same as for conventional products. However, the general repercussions of such applications were also the same as for conventional products; some regulatory regimes involve regulatory approval prior to undertaking the particular regulated activity. This, in tur, meant that steps not required to be taken under particular regulatory frameworks were also not taken for NMs. Nevertheless, some gaps were found where the regulatory frameworks either do not apply at all to NMs and products incorporating them or do not apply to NMs or nanoproducts as appropriately as they apply to conventional products in the same families. |
| Archived Copy: |
Attachment_3_PDF_420_2280.pdf |
|
|
| Report Title: |
Attachment 2 - Indicative List of Nanomaterials. |
| Report ID: |
419 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment Scheme |
| Report Type: |
Background Document |
| URL: |
[Attachment_2_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
This attachment contains an indicative, but by no means exhaustive, list of substances that the National Industrial Chemicals Notification and Assessment Scheme considers to be produced as industrial nanomaterials. |
| Archived Copy: |
Attachment_2_PDF_419_9730.pdf |
|
|
| Report Title: |
Attachment 1: Overarching Principles of the NICNAS Regulatory Strategy |
| Report ID: |
418 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment Scheme |
| Report Type: |
Background Document |
| URL: |
[Attachment_1_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
This attachment highlights essential principles for managing the risks posed by new technologies (including nanotechnology) to health and safety of people and the environment. Chief among them is reviewing the ability of the existing regulatory framework to deliver an efficient and effective response to the new technology while also being mindful that any risk from use of the nano-form of a chemical is no greater than that posed by the conventional form of the chemical or it is at or below the level of acceptable risk. Equally important is a second principle, that in managing risk one should make use of the best scientific evidence available for risk based assessment of the impacts of the new technology on human health and the environment, including the ability to review decisions as new scientific evidence becomes available. Finally, where best available scientific evidence is insufficient to support the safety of the product/chemical, measures to protect public health and safety and the environment can be adopted. |
| Archived Copy: |
Attachment_1_PDF_418_7501.pdf |
|
|
| Report Title: |
Proposal for Regulatory Reform of Industrial; Public Discussion Paper |
| Report ID: |
413 |
| Date: |
11/1/2009 |
| Author: |
National Industrial Chemicals Notification and Assessment Scheme |
| Report Type: |
Concept Paper |
| URL: |
[NICNAS_Nano_PUBLIC_DISCUSSION_PAPER_PDF.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
This paper provides NICNAS’s stakeholders (the community, industry and government) with the opportunity to comment to NICNAS on a reform initiative to introduce new approaches to the regulation of industrial nanomaterials. The proposal utilizes the existing NICNAS framework, and proposes some adjustments to address uncertainties in potential risks posed by these novel materials to health, safety and the environment. The proposal addresses three elements: regulation of nanoforms of new chemicals, regulation of nanoforms of existing chemicals, and the principle of an integrated approach for industrial nanomaterials within the NICNAS framework as a longer term strategy. As part of this paper, NICNAS is seeking input from stakeholders regarding whether it provides for the sound management of industrial nanomaterials and whether it establishes a clear, regulatory framework for ensuring public health, worker safety, and environmental standards. |
| Archived Copy: |
NICNAS_Nano_PUBLIC_DISCUSSION_PAPER_PDF_413_8973.pdf |
|
|
| Report Title: |
Updated Arrangements for Approved Uv Filters and Assessment of New Uv Filters Used in Cosmetics |
| Report ID: |
165 |
| Date: |
10/7/2008 |
| Author: |
Government of Australia: Department of Ageing and National Industrial Chemical Notification and Assessment Scheme |
| Report Type: |
Guidance Document |
| URL: |
[2008oct_whole.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
The purpose of this notice is to advise companies of the notification and assessment requirements for UV filters in cosmetic products that fall within the scope of the Industrial Chemicals Notification and Assessment Act 1989. The National Industrial Chemical Notification and Assessment Scheme (NICNAS) had received enquiries regarding the notification requirements for UV filters in cosmetic products. In January 2007 NICNAS published in the Chemical Gazette a notice describing new arrangements for UV filters proposed for use in cosmetic products as well as products covered under the former Cosmetic Interim Arrangement. These legislative changes resulted in the introduction of a Cosmetic Standard which describes the regulatory requirements for six cosmetic product categories with much attention placed on product categories containing sunscreens.
|
| Archived Copy: |
2008oct_whole_165_2476.pdf |
|
|
| Report Title: |
A review of the scientific literature on the safety of nanoparticulate titanium dioxide or zinc oxide in sunscreens |
| Report ID: |
121 |
| Date: |
1/16/2006 |
| Report Type: |
Summary Article |
| URL: |
[sunscreen-zotd.pdf] |
| Country: |
Australia |
| Organization: |
Department of Health and Ageing, Therapeutic Goods Administration (Australian government) |
| Summary: |
This Australian government article summarizes existing research regarding the safety of nanoparticle sunscreens containing zinc oxide or titanium dioxide. The use of nanoparticles on the human skin has been identified as potentially dangerous. This document summarizes 24 scientific studies relating to nanoparticles and the skin. It finds some studies linking exposure to zinc oxide and titanium dioxide to free radical production and adverse effects. Other studies involving dermal penetration found that these nanoparticles did not penetrate into lower levels of the skin. Based upon the research summarized, the report concludes that nanoparticles in sunscreens remain on the surface (outer dead layer) of the skin and thus do not pose a health hazard. |
|
|
|